Literature DB >> 11590206

Apolipoprotein E and mimetic peptide initiate a calcium-dependent signaling response in macrophages.

U K Misra1, C L Adlakha, G Gawdi, M K McMillian, S V Pizzo, D T Laskowitz.   

Abstract

Apolipoprotein E (ApoE) is a 34-kDa cholesterol transport protein that also possesses immunomodulatory properties. In this study, we demonstrate that ApoE initiates a signaling cascade in murine peritoneal macrophages that leads to increased production of inositol triphosphate with mobilization of intracellular Ca(2+) stores. This cascade is inhibited by pretreatment with receptor-associated protein and Ni(2+), and it is mediated by a pertussis toxin-sensitive G protein. These properties are characteristic of signal transduction induced via ligand binding to the cellular receptor, lipoprotein receptor-related protein. A peptide derived from the receptor-binding region of ApoE also initiates signal transduction in a manner similar to that of the intact protein, suggesting that this isolated region is sufficient for signal transduction. The ApoE-mimetic peptide competed for binding with the intact protein, confirming that they both interact with the same site. ApoE-dependent signal transduction might play a role in mediating the functional properties of this lipoprotein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11590206

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  28 in total

Review 1.  Apolipoprotein E-induced cell signaling in the vessel wall.

Authors:  David Y Hui
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

2.  COG1410, a novel apolipoprotein-E mimetic, improves functional and morphological recovery in a rat model of focal brain ischemia.

Authors:  Elena A Tukhovskaya; Alexey Yu Yukin; Oksana N Khokhlova; Arkady N Murashev; Michael P Vitek
Journal:  J Neurosci Res       Date:  2009-02-15       Impact factor: 4.164

Review 3.  The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis.

Authors:  Hong-liang Zhang; Jiang Wu; Jie Zhu
Journal:  J Biomed Biotechnol       Date:  2010-02-16

4.  Apolipoprotein E negatively regulates house dust mite-induced asthma via a low-density lipoprotein receptor-mediated pathway.

Authors:  Xianglan Yao; Karin Fredriksson; Zu-Xi Yu; Xiuli Xu; Nalini Raghavachari; Karen J Keeran; Gayle J Zywicke; Minjung Kwak; Marcelo J A Amar; Alan T Remaley; Stewart J Levine
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

5.  The apoE-mimetic peptide, COG1410, improves functional recovery in a murine model of intracerebral hemorrhage.

Authors:  Daniel T Laskowitz; Beilei Lei; Hana N Dawson; Haichen Wang; Steven T Bellows; Dale J Christensen; Michael P Vitek; Michael L James
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

Review 6.  Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.

Authors:  Li Shan Chiu; Ryan S Anderton; Neville W Knuckey; Bruno P Meloni
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

Review 7.  Therapeutic Development of Apolipoprotein E Mimetics for Acute Brain Injury: Augmenting Endogenous Responses to Reduce Secondary Injury.

Authors:  Michael L James; Jordan M Komisarow; Haichen Wang; Daniel T Laskowitz
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

Review 8.  Dantrolene, a treatment for Alzheimer disease?

Authors:  Li Liang; Huafeng Wei
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jan-Mar       Impact factor: 2.703

Review 9.  The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  Hong-Liang Zhang; Jiang Wu; Jie Zhu
Journal:  Clin Dev Immunol       Date:  2010-05-31

10.  A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage.

Authors:  Junling Gao; Haichen Wang; Huaxin Sheng; John R Lynch; David S Warner; Lori Durham; Michael P Vitek; Daniel T Laskowitz
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.